Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization. [electronic resource]
Producer: 20101213Description: 363-75 p. digitalISSN:- 1875-2128
- Acute Coronary Syndrome -- drug therapy
- Adrenergic beta-Antagonists -- therapeutic use
- Adult
- Aged
- Aged, 80 and over
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Angiotensin-Converting Enzyme Inhibitors -- therapeutic use
- Cardiovascular Agents -- therapeutic use
- Databases as Topic
- Disease-Free Survival
- Drug Prescriptions
- Drug Therapy, Combination
- Evidence-Based Medicine
- Female
- France -- epidemiology
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Insurance, Pharmaceutical Services
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Myocardial Infarction -- drug therapy
- Odds Ratio
- Patient Readmission -- statistics & numerical data
- Platelet Aggregation Inhibitors -- therapeutic use
- Proportional Hazards Models
- Risk Assessment
- Risk Factors
- Time Factors
- Treatment Outcome
- Assessment of Medication Adherence
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.